 | • レポートコード：MRC2012B0072 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、自己免疫疾患治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。自己免疫疾患治療薬の種類別市場規模（免疫抑制剤、抗炎症薬、コルチコステロイド、非ステロイド性抗炎症薬、生物製剤、その他）、用途別市場規模（病院、診療所、独立薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Amgen、Merck、Novartis、Bristol-Myers Squibb、Johnson & Johnson Services、F. Hoffmann-La Roche、Abott、Sanofi、Bayer、Eli Lilly and Company、 ・地域別グローバル市場分析 2015年-2020年 ・自己免疫疾患治療薬の北米市場（アメリカ、カナダ、メキシコ） ・自己免疫疾患治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・自己免疫疾患治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・自己免疫疾患治療薬の南米市場（ブラジル、アルゼンチン） ・自己免疫疾患治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：免疫抑制剤、抗炎症薬、コルチコステロイド、非ステロイド性抗炎症薬、生物製剤、その他 ・用途別分析：病院、診療所、独立薬局、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Autoimmune Disease Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 111090 million by 2025, from USD 101510 million in 2019.
The Autoimmune Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Autoimmune Disease Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Autoimmune Disease Therapeutics market has been segmented into:
Immunosuppressants
Anti-Inflammatory Drugs
Corticosteroids
Nonsteroidal Anti-inflammatory Drugs
Biologics
Other
By Application, Autoimmune Disease Therapeutics has been segmented into:
Hospitals
Clinics
Independent Pharmacies
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Autoimmune Disease Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Autoimmune Disease Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Autoimmune Disease Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Autoimmune Disease Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Autoimmune Disease Therapeutics Market Share Analysis
Autoimmune Disease Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Autoimmune Disease Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Autoimmune Disease Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Autoimmune Disease Therapeutics are:
Pfizer
Amgen
Merck
Novartis
Bristol-Myers Squibb
Johnson & Johnson Services
F. Hoffmann-La Roche
Abott
Sanofi
Bayer
Eli Lilly and Company
Table of Contents
1 Autoimmune Disease Therapeutics Market Overview
1.1 Product Overview and Scope of Autoimmune Disease Therapeutics
1.2 Classification of Autoimmune Disease Therapeutics by Type
1.2.1 Global Autoimmune Disease Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Autoimmune Disease Therapeutics Revenue Market Share by Type in 2019
1.2.3 Immunosuppressants
1.2.4 Anti-Inflammatory Drugs
1.2.5 Corticosteroids
1.2.6 Nonsteroidal Anti-inflammatory Drugs
1.2.7 Biologics
1.2.8 Other
1.3 Global Autoimmune Disease Therapeutics Market by Application
1.3.1 Overview: Global Autoimmune Disease Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Independent Pharmacies
1.3.5 Other
1.4 Global Autoimmune Disease Therapeutics Market by Regions
1.4.1 Global Autoimmune Disease Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Autoimmune Disease Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Autoimmune Disease Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Autoimmune Disease Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Autoimmune Disease Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Autoimmune Disease Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Autoimmune Disease Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Autoimmune Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Amgen SWOT Analysis
2.2.4 Amgen Product and Services
2.2.5 Amgen Autoimmune Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Autoimmune Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Autoimmune Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bristol-Myers Squibb SWOT Analysis
2.5.4 Bristol-Myers Squibb Product and Services
2.5.5 Bristol-Myers Squibb Autoimmune Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson Services
2.6.1 Johnson & Johnson Services Details
2.6.2 Johnson & Johnson Services Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson Services SWOT Analysis
2.6.4 Johnson & Johnson Services Product and Services
2.6.5 Johnson & Johnson Services Autoimmune Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 F. Hoffmann-La Roche
2.7.1 F. Hoffmann-La Roche Details
2.7.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 F. Hoffmann-La Roche SWOT Analysis
2.7.4 F. Hoffmann-La Roche Product and Services
2.7.5 F. Hoffmann-La Roche Autoimmune Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Abott
2.8.1 Abott Details
2.8.2 Abott Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Abott SWOT Analysis
2.8.4 Abott Product and Services
2.8.5 Abott Autoimmune Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sanofi SWOT Analysis
2.9.4 Sanofi Product and Services
2.9.5 Sanofi Autoimmune Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bayer
2.10.1 Bayer Details
2.10.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bayer SWOT Analysis
2.10.4 Bayer Product and Services
2.10.5 Bayer Autoimmune Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Eli Lilly and Company
2.11.1 Eli Lilly and Company Details
2.11.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Eli Lilly and Company SWOT Analysis
2.11.4 Eli Lilly and Company Product and Services
2.11.5 Eli Lilly and Company Autoimmune Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Autoimmune Disease Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Autoimmune Disease Therapeutics Players Market Share
3.2.2 Top 10 Autoimmune Disease Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Autoimmune Disease Therapeutics Revenue and Market Share by Regions
4.2 North America Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Autoimmune Disease Therapeutics Revenue by Countries
5.1 North America Autoimmune Disease Therapeutics Revenue by Countries (2015-2020)
5.2 USA Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Autoimmune Disease Therapeutics Revenue by Countries
6.1 Europe Autoimmune Disease Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Autoimmune Disease Therapeutics Revenue by Countries
7.1 Asia-Pacific Autoimmune Disease Therapeutics Revenue by Countries (2015-2020)
7.2 China Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Autoimmune Disease Therapeutics Revenue by Countries
8.1 South America Autoimmune Disease Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Autoimmune Disease Therapeutics by Countries
9.1 Middle East & Africa Autoimmune Disease Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Autoimmune Disease Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Autoimmune Disease Therapeutics Market Forecast by Type (2019-2024)
10.3 Immunosuppressants Revenue Growth Rate (2015-2025)
10.4 Anti-Inflammatory Drugs Revenue Growth Rate (2015-2025)
10.5 Corticosteroids Revenue Growth Rate (2015-2025)
10.6 Nonsteroidal Anti-inflammatory Drugs Revenue Growth Rate (2015-2025)
10.7 Biologics Revenue Growth Rate (2015-2025)
10.8 Other Revenue Growth Rate (2015-2025)
11 Global Autoimmune Disease Therapeutics Market Segment by Application
11.1 Global Autoimmune Disease Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Autoimmune Disease Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Independent Pharmacies Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Autoimmune Disease Therapeutics Market Size Forecast (2021-2025)
12.1 Global Autoimmune Disease Therapeutics Market Size Forecast (2021-2025)
12.2 Global Autoimmune Disease Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Autoimmune Disease Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Autoimmune Disease Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Autoimmune Disease Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Autoimmune Disease Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Autoimmune Disease Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Autoimmune Disease Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Autoimmune Disease Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Autoimmune Disease Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Autoimmune Disease Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Autoimmune Disease Therapeutics Major Business
Table 7. Pfizer Autoimmune Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Autoimmune Disease Therapeutics Product and Solutions
Table 10. Pfizer Autoimmune Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Amgen Corporate Information, Location and Competitors
Table 12. Amgen Autoimmune Disease Therapeutics Major Business
Table 13. Amgen Autoimmune Disease Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Amgen SWOT Analysis
Table 15. Amgen Autoimmune Disease Therapeutics Product and Solutions
Table 16. Amgen Autoimmune Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Merck Corporate Information, Location and Competitors
Table 18. Merck Autoimmune Disease Therapeutics Major Business
Table 19. Merck Autoimmune Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Merck SWOT Analysis
Table 21. Merck Autoimmune Disease Therapeutics Product and Solutions
Table 22. Merck Autoimmune Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novartis Corporate Information, Location and Competitors
Table 24. Novartis Autoimmune Disease Therapeutics Major Business
Table 25. Novartis Autoimmune Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. Novartis SWOT Analysis
Table 27. Novartis Autoimmune Disease Therapeutics Product and Solutions
Table 28. Novartis Autoimmune Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 30. Bristol-Myers Squibb Autoimmune Disease Therapeutics Major Business
Table 31. Bristol-Myers Squibb Autoimmune Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Bristol-Myers Squibb SWOT Analysis
Table 33. Bristol-Myers Squibb Autoimmune Disease Therapeutics Product and Solutions
Table 34. Bristol-Myers Squibb Autoimmune Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Johnson & Johnson Services Corporate Information, Location and Competitors
Table 36. Johnson & Johnson Services Autoimmune Disease Therapeutics Major Business
Table 37. Johnson & Johnson Services Autoimmune Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Johnson & Johnson Services SWOT Analysis
Table 39. Johnson & Johnson Services Autoimmune Disease Therapeutics Product and Solutions
Table 40. Johnson & Johnson Services Autoimmune Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. F. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 42. F. Hoffmann-La Roche Autoimmune Disease Therapeutics Major Business
Table 43. F. Hoffmann-La Roche Autoimmune Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. F. Hoffmann-La Roche SWOT Analysis
Table 45. F. Hoffmann-La Roche Autoimmune Disease Therapeutics Product and Solutions
Table 46. F. Hoffmann-La Roche Autoimmune Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Abott Corporate Information, Location and Competitors
Table 48. Abott Autoimmune Disease Therapeutics Major Business
Table 49. Abott Autoimmune Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. Abott SWOT Analysis
Table 51. Abott Autoimmune Disease Therapeutics Product and Solutions
Table 52. Abott Autoimmune Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Sanofi Corporate Information, Location and Competitors
Table 54. Sanofi Autoimmune Disease Therapeutics Major Business
Table 55. Sanofi Autoimmune Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 56. Sanofi SWOT Analysis
Table 57. Sanofi Autoimmune Disease Therapeutics Product and Solutions
Table 58. Sanofi Autoimmune Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bayer Corporate Information, Location and Competitors
Table 60. Bayer Autoimmune Disease Therapeutics Major Business
Table 61. Bayer Autoimmune Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 62. Bayer SWOT Analysis
Table 63. Bayer Autoimmune Disease Therapeutics Product and Solutions
Table 64. Bayer Autoimmune Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Eli Lilly and Company Corporate Information, Location and Competitors
Table 66. Eli Lilly and Company Autoimmune Disease Therapeutics Major Business
Table 67. Eli Lilly and Company Autoimmune Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 68. Eli Lilly and Company SWOT Analysis
Table 69. Eli Lilly and Company Autoimmune Disease Therapeutics Product and Solutions
Table 70. Eli Lilly and Company Autoimmune Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Autoimmune Disease Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 72. Global Autoimmune Disease Therapeutics Revenue Share by Players (2015-2020)
Table 73. Global Autoimmune Disease Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Autoimmune Disease Therapeutics Revenue Market Share by Regions (2015-2020)
Table 75. North America Autoimmune Disease Therapeutics Revenue by Countries (2015-2020)
Table 76. North America Autoimmune Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Table 77. Europe Autoimmune Disease Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Autoimmune Disease Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Autoimmune Disease Therapeutics Revenue by Countries (2015-2020)
Table 80. South America Autoimmune Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Autoimmune Disease Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Autoimmune Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Table 83. Global Autoimmune Disease Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 84. Global Autoimmune Disease Therapeutics Revenue Share by Type (2015-2020)
Table 85. Global Autoimmune Disease Therapeutics Revenue Forecast by Type (2021-2025)
Table 86. Global Autoimmune Disease Therapeutics Revenue by Application (2015-2020)
Table 87. Global Autoimmune Disease Therapeutics Revenue Share by Application (2015-2020)
Table 88. Global Autoimmune Disease Therapeutics Revenue Forecast by Application (2021-2025)
Table 89. Global Autoimmune Disease Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Autoimmune Disease Therapeutics Picture
Figure 2. Global Autoimmune Disease Therapeutics Revenue Market Share by Type in 2019
Figure 3. Immunosuppressants Picture
Figure 4. Anti-Inflammatory Drugs Picture
Figure 5. Corticosteroids Picture
Figure 6. Nonsteroidal Anti-inflammatory Drugs Picture
Figure 7. Biologics Picture
Figure 8. Other Picture
Figure 9. Autoimmune Disease Therapeutics Revenue Market Share by Application in 2019
Figure 10. Hospitals Picture
Figure 11. Clinics Picture
Figure 12. Independent Pharmacies Picture
Figure 13. Other Picture
Figure 14. Global Autoimmune Disease Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Autoimmune Disease Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Autoimmune Disease Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Autoimmune Disease Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Autoimmune Disease Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Autoimmune Disease Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Autoimmune Disease Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Autoimmune Disease Therapeutics Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Autoimmune Disease Therapeutics Revenue Market Share in 2019
Figure 23. Global Top 10 Players Autoimmune Disease Therapeutics Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Autoimmune Disease Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Autoimmune Disease Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 27. Global Autoimmune Disease Therapeutics Revenue Market Share by Regions in 2018
Figure 28. North America Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. Europe Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 31. South America Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. North America Autoimmune Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 34. North America Autoimmune Disease Therapeutics Revenue Market Share by Countries in 2019
Figure 35. USA Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 36. Canada Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. Europe Autoimmune Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Autoimmune Disease Therapeutics Revenue Market Share by Countries in 2019
Figure 40. Germany Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. UK Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. France Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 43. Russia Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 44. Italy Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Autoimmune Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Autoimmune Disease Therapeutics Revenue Market Share by Countries in 2019
Figure 47. China Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. Japan Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. Korea Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 50. India Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 52. South America Autoimmune Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 53. South America Autoimmune Disease Therapeutics Revenue Market Share by Countries in 2019
Figure 54. Brazil Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Autoimmune Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Autoimmune Disease Therapeutics Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. UAE Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Autoimmune Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 62. Global Autoimmune Disease Therapeutics Revenue Share by Type (2015-2020)
Figure 63. Global Autoimmune Disease Therapeutics Revenue Share by Type in 2019
Figure 64. Global Autoimmune Disease Therapeutics Market Share Forecast by Type (2021-2025)
Figure 65. Global Immunosuppressants Revenue Growth Rate (2015-2020)
Figure 66. Global Anti-Inflammatory Drugs Revenue Growth Rate (2015-2020)
Figure 67. Global Corticosteroids Revenue Growth Rate (2015-2020)
Figure 68. Global Nonsteroidal Anti-inflammatory Drugs Revenue Growth Rate (2015-2020)
Figure 69. Global Biologics Revenue Growth Rate (2015-2020)
Figure 70. Global Other Revenue Growth Rate (2015-2020)
Figure 71. Global Autoimmune Disease Therapeutics Revenue Share by Application (2015-2020)
Figure 72. Global Autoimmune Disease Therapeutics Revenue Share by Application in 2019
Figure 73. Global Autoimmune Disease Therapeutics Market Share Forecast by Application (2021-2025)
Figure 74. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 75. Global Clinics Revenue Growth Rate (2015-2020)
Figure 76. Global Independent Pharmacies Revenue Growth Rate (2015-2020)
Figure 77. Global Other Revenue Growth Rate (2015-2020)
Figure 78. Global Autoimmune Disease Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Autoimmune Disease Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Autoimmune Disease Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Autoimmune Disease Therapeutics Revenue Market Forecast (2021-2025)
Figure 82. Europe Autoimmune Disease Therapeutics Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Autoimmune Disease Therapeutics Revenue Market Forecast (2021-2025)
Figure 84. South America Autoimmune Disease Therapeutics Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Autoimmune Disease Therapeutics Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
自己免疫疾患診断の世界市場（～2026年） The diagnosis of autoimmune diseases depends on the identification of disease-associated clinical symptoms and is associated with the detection of autoantibodies. Clinicians conventionally classify autoimmune diseases as either systemic or organ-specific. In terms of geography, the Americas led the …- 自己免疫治療薬の世界市場（～2026年） Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by c…
- 自己免疫・炎症性免疫調節剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Autoimmune and Inflammatory Immunomodulators market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …
- 自己免疫・炎症性免疫調節剤の世界市場（～2026年） Market Analysis and Insights: Global Autoimmune and Inflammatory Immunomodulators Market The global Autoimmune and Inflammatory Immunomodulators market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Autoimmune and Inflammato…
- 炎症性腸疾患（IBD）の世界市場（～2026年） Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stom…